Jefferies Group LLC Intercept Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $34,633 - $60,415	3,084 New	3,084 $6,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $371,431 - $494,223	-27,781 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $396,712 - $542,562	27,781 New	27,781 $199,000
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $433,107 - $845,826	-22,406 Closed	0 $0
Q4 2020 Sep 21, 2023	BUY	$24.48 - $42.47 $548,498 - $951,582	22,406 New	22,406 $553,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $79,584 - $138,069	3,251 Added 16.97%	22,406 $553,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $579,821 - $792,675	14,833 Added 343.2%	19,155 $794,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $47,587 - $93,788	1,019 Added 30.85%	4,322 $207,000
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $1.25 Million - $3.08 Million	-25,955 Reduced 88.71%	3,303 $208,000
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $1.65 Million - $3.56 Million	28,708 Added 5219.64%	29,258 $3.63 Million
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $1.76 Million - $2.42 Million	-30,070 Reduced 98.2%	550 $36,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $2.27 Million - $3.53 Million	29,211 Added 2073.17%	30,620 $2.44 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $118,093 - $155,194	-1,286 Reduced 47.72%	1,409 $158,000
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $231,204 - $340,809	2,695 New	2,695 $272,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $3.5 Million - $4.46 Million	-66,313 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $11.2 Million - $14 Million	-192,446 Reduced 74.37%	66,313 $3.87 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $14.8 Million - $30.7 Million	258,759	258,759 $15 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account